Finally, our data may also help in proposing further research into therapies employing CX3CR1 antagonists (AZD8797) (41) or humanised monoclonal antibody of IL-17A (ixekizumab) (42, 43) as potential therapeutic targets in sepsis. Here, CX3CR1 is linked to Sepsis.